Genesis HealthCare (GEN) Tops Q3 EPS by 12c; Guidance Reaffirmed

Genesis HealthCare (NYSE: GEN) reported Q3 EPS of ($0.28), $0.12 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $1.42 billion versus the consensus estimate of $1.39 billion.Genesis HealthCare reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance